ロード中...
Current State of Commercial Point-of-Care Nucleic Acid Tests for Infectious Diseases
The COVID-19 pandemic has put the spotlight on the urgent need for integrated nucleic acid tests (NATs) for infectious diseases, especially those that can be used near patient (“point-of-care”, POC), with rapid results and low cost, but without sacrificing sensitivity or specificity of gold standard...
保存先:
| 出版年: | Analyst |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8139840/ https://ncbi.nlm.nih.gov/pubmed/33899053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/d0an01988g |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|